Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Alten

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Pediatric Blood & Cancer|April 4, 2017
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhoodJuliane Schmäh, Birthe Fedders, Renate Panzer-Grümayer, et al.
Blood|July 13, 2017
An Fc-engineered CD19 antibody eradicates MRD in patient-derived <i>MLL</i>-rearranged acute lymphoblastic leukemia xenograftsDenis M Schewe, Ameera Alsadeq, Cornelia Sattler, et al.
British Journal of Haematology|February 24, 2026
Invasive yeast infection in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009Andreas H Groll, Simone Cesaro, Julia Alten, et al.
Leukemia|December 12, 2022
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009Thomas Lehrnbecher, Andreas H Groll, Simone Cesaro, et al.
Leukemia|April 26, 2023
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcomeMarius Külp, Patrizia Larghero, Julia Alten, et al.
Leukemia|October 16, 2023
Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALLŽeljko Antić, Alena van Bömmel, Konstantin Riege, et al.
Cancers|November 27, 2021
Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved DiagnosticsPhilippe Chouvarine, Željko Antić, Jana Lentes, et al.
Iscience|July 8, 2022
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemiaMarius Külp, Anna Lena Siemund, Patrizia Larghero, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2022
Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studiesFrancesco Ceppi, Giacomo Gotti, Anja Möricke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Pediatric Blood & Cancer|April 4, 2017
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhoodJuliane Schmäh, Birthe Fedders, Renate Panzer-Grümayer, et al.
Blood|July 13, 2017
An Fc-engineered CD19 antibody eradicates MRD in patient-derived <i>MLL</i>-rearranged acute lymphoblastic leukemia xenograftsDenis M Schewe, Ameera Alsadeq, Cornelia Sattler, et al.
British Journal of Haematology|February 24, 2026
Invasive yeast infection in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009Andreas H Groll, Simone Cesaro, Julia Alten, et al.
Leukemia|December 12, 2022
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009Thomas Lehrnbecher, Andreas H Groll, Simone Cesaro, et al.
Leukemia|April 26, 2023
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcomeMarius Külp, Patrizia Larghero, Julia Alten, et al.
Leukemia|October 16, 2023
Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALLŽeljko Antić, Alena van Bömmel, Konstantin Riege, et al.
Cancers|November 27, 2021
Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved DiagnosticsPhilippe Chouvarine, Željko Antić, Jana Lentes, et al.
Iscience|July 8, 2022
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemiaMarius Külp, Anna Lena Siemund, Patrizia Larghero, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2022
Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studiesFrancesco Ceppi, Giacomo Gotti, Anja Möricke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.
Pageof 4